Variant report
Variant | esv1841819 |
---|---|
Chromosome Location | chr2:96669134-96674509 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:96672680-96672830 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr2:96672420-96672570 | SK-N-SH_RA | brain: | n/a | chr2:96672441-96672454 chr2:96672435-96672453 chr2:96672438-96672451 |
3 | FOXA2 | chr2:96671438-96671649 | HepG2 | liver: | n/a | n/a |
4 | MYC | chr2:96672816-96672917 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | POLR2A | chr2:96669888-96669943 | A549 | lung: | n/a | n/a |
6 | POLR2A | chr2:96670581-96670605 | A549 | lung: | n/a | n/a |
7 | POLR2A | chr2:96670432-96670579 | A549 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:96673978-96674028 | CMK | blood: | n/a |
2 | chr2:96673978-96674028 | HEEpiC | esophagus: | n/a |
3 | chr2:96673978-96674028 | NT2-D1 | testis: | n/a |
4 | chr2:96673978-96674028 | HRE | kidney: | n/a |
5 | chr2:96673978-96674028 | HEK293 | kidney: | embryo |
6 | chr2:96673978-96674028 | GM12892 | blood: | n/a |
7 | chr2:96673978-96674028 | AG09319 | gingival: | n/a |
8 | chr2:96673978-96674028 | HL-60 | blood: | n/a |
9 | chr2:96673978-96674028 | BJ | skin: | n/a |
10 | chr2:96673978-96674028 | AG04449 | skin: | fetal |
11 | chr2:96673978-96674028 | SAEC | small airway: | n/a |
12 | chr2:96673978-96674028 | Hepatocyte | liver: | n/a |
13 | chr2:96673978-96674028 | AG09309 | skin: | n/a |
14 | chr2:96673978-96674028 | NHDF-neo | bronchial: | n/a |
15 | chr2:96673978-96674028 | MCF10A-Er-Src | breast: | n/a |
16 | chr2:96673978-96674028 | A549 | lung: | n/a |
17 | chr2:96673978-96674028 | NHBE | bronchial: | n/a |
18 | chr2:96673978-96674028 | HRCEpiC | kidney: | n/a |
19 | chr2:96673978-96674028 | SK-N-SH_RA | brain: | n/a |
20 | chr2:96673978-96674028 | GM06990 | blood: | n/a |
21 | chr2:96673978-96674028 | BE2_C | brain: | n/a |
22 | chr2:96673978-96674028 | HCPEpiC | choroid plexus: | n/a |
23 | chr2:96673978-96674028 | K562 | blood: | n/a |
24 | chr2:96673978-96674028 | PFSK-1 | brain: | n/a |
25 | chr2:96673978-96674028 | RPTEC | kidney: | n/a |
26 | chr2:96673978-96674028 | HRPEpiC | eye: | n/a |
27 | chr2:96673978-96674028 | ECC-1 | luminal epithelium: | n/a |
28 | chr2:96673978-96674028 | NB4 | blood: | n/a |
29 | chr2:96673978-96674028 | LNCaP | prostate: | n/a |
30 | chr2:96673978-96674028 | PANC-1 | pancreas: | n/a |
31 | chr2:96673978-96674028 | GM12891 | blood: | n/a |
32 | chr2:96673978-96674028 | H1-hESC | embryonic stem cell: | embryo |
33 | chr2:96673978-96674028 | SKMC | muscle: | n/a |
34 | chr2:96673978-96674028 | HCM | heart: | n/a |
35 | chr2:96673978-96674028 | HMEC | breast: | n/a |
36 | chr2:96673978-96674028 | HCF | heart: | n/a |
37 | chr2:96673978-96674028 | GM19239 | blood: | n/a |
38 | chr2:96673978-96674028 | PrEC | prostate: | n/a |
39 | chr2:96673978-96674028 | T-47D | breast: | n/a |
40 | chr2:96673978-96674028 | HAEpiC | amniotic membrane: | n/a |
41 | chr2:96673978-96674028 | HIPEpiC | eye: | n/a |
42 | chr2:96673978-96674028 | HCT-116 | colon: | n/a |
43 | chr2:96673978-96674028 | Caco-2 | colon: | n/a |
44 | chr2:96673978-96674028 | HNPCEpiC | eye: | n/a |
45 | chr2:96673978-96674028 | AoSMC | blood vessel: | n/a |
46 | chr2:96673978-96674028 | GM12878 | blood: | n/a |
47 | chr2:96673978-96674028 | IMR90 | lung: | fetal |
48 | chr2:96673978-96674028 | MCF-7 | breast: | n/a |
49 | chr2:96673978-96674028 | HPAEpiC | pulmonary alveolar: | n/a |
50 | chr2:96673978-96674028 | Hela-S3 | cervix: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:96673991..96676008-chr2:96873030..96875575,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANKRD36C-3 | chr2:96670313-96670601 | NONHSAT072529 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SL210P | TF binding region |
FAHD2CP | TF binding region |
RN7SL210P | CpG island |
FAHD2CP | CpG island |
ENSG00000084090 | chromatin interactions |
ENSG00000204685 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535801257 | chr2:96670324-96670325 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs552661429 | chr2:96670483-96670484 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs183900589 | chr2:96670491-96670492 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs190379416 | chr2:96670497-96670498 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs533555847 | chr2:96670515-96670516 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs564910332 | chr2:96670557-96670558 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs545980485 | chr2:96671485-96671486 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs536393443 | chr2:96671580-96671581 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs562955029 | chr2:96671627-96671628 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs567748286 | chr2:96671648-96671649 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs561931822 | chr2:96672424-96672425 | Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs371785599 | chr2:96672471-96672472 | Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs76001175 | chr2:96672526-96672527 | Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs531221015 | chr2:96672583-96672584 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547681372 | chr2:96672756-96672757 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs570762788 | chr2:96672757-96672758 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs532020020 | chr2:96672769-96672770 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs565548366 | chr2:96672770-96672771 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs577627552 | chr2:96672787-96672788 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs186631884 | chr2:96672836-96672837 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs562966645 | chr2:96672856-96672857 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs568878061 | chr2:96672900-96672901 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs548175392 | chr2:96673979-96673980 | Inactive region | CpG island | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs561790917 | chr2:96674005-96674006 | Enhancers | CpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs138643748 | chr2:96674012-96674013 | Enhancers | CpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs527362949 | chr2:96674016-96674017 | Enhancers | CpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs547648119 | chr2:96674046-96674047 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs570616370 | chr2:96674048-96674049 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs2692947 | chr2:96674116-96674117 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs376980774 | chr2:96674181-96674182 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs140404790 | chr2:96674229-96674230 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs370066787 | chr2:96674244-96674245 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs535471843 | chr2:96674307-96674308 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs545372046 | chr2:96674314-96674315 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs150363943 | chr2:96674324-96674325 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs185780698 | chr2:96674341-96674342 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs200276702 | chr2:96674352-96674353 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs534774911 | chr2:96674416-96674417 | Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs558107777 | chr2:96674448-96674449 | Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs578119641 | chr2:96674453-96674454 | Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Neuroblastoma | 18574593 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Epilepsy | 22083797 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:96672400-96672600 | Bivalent/Poised TSS | Fetal Muscle Trunk | muscle |
2 | chr2:96674000-96674400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:96674400-96674600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |